Haemonetics Corp. buy BTIG Research
Start price
26.06.26
/
50%
€68.00
Target price
26.06.27
€73.86
Performance (%)
7.35%
Price
28.07.26
€73.00
Summary
This prediction is currently active. With a performance of 7.35%, the BUY prediction by BTIG_Research for Haemonetics Corp. is trending in the right direction. This prediction currently runs until 26.06.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 5.797% | 5.797% |
| iShares Core DAX® | 3.901% | 2.667% |
| iShares Nasdaq 100 | -2.603% | -7.934% |
| iShares Nikkei 225® | -0.545% | -9.754% |
| iShares S&P 500 | -0.881% | -1.488% |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (HAE) had its "buy" rating reaffirmed by BTIG Research. They now have a $84.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€64.00
17.06.26
17.06.26
€72.34
17.06.27
17.06.27
14.06%
28.07.26
28.07.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€48.40
06.02.26
06.02.26
€74.64
06.02.27
06.02.27
50.83%
28.07.26
28.07.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
26.96%
28.07.26
28.07.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25